The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines-Reference-Cited by-同舟云学术

The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines

Published:2007-10 Issue:42 Volume:25 Page:7372-7378
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Wright Peter F.,Karron Ruth A.,Belshe Robert B.,Shi Jian R.,Randolph Valerie B.,Collins Peter L.,O'Shea Alice F.,Gruber William C.,Murphy Brian R.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference21 articles.

1. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants;Karron;J Infect Dis,2005

2. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children;Karron;J Infect Dis,1997

3. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy;Wright;J Infect Dis,2000

4. The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans;Wright;J Infect Dis,2006

5. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population;Chin;Am J Epidemiol,1969

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intranasal respiratory syncytial virus vaccine attenuated by codon-pair deoptimization of seven open reading frames is genetically stable and elicits mucosal and systemic immunity and protection against challenge virus replication in hamsters;PLOS Pathogens;2024-05-13

2. Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate ΔNS2/Δ1313/I1314L increase the stability of infectivity and content of prefusion F protein;PLOS ONE;2024-04-09

3. Respiratory syncytial virus immunoprophylaxis: Novel opportunities and a call for equity;Journal of Medical Virology;2024-02

4. Preventative therapies for respiratory Syncytial virus (RSV) in children: Where are we now?;Paediatric Respiratory Reviews;2023-08

5. Evaluation of the Live-Attenuated Intranasal Respiratory Syncytial Virus (RSV) Vaccine RSV/6120/ΔNS2/1030s in RSV-Seronegative Young Children;The Journal of Infectious Diseases;2023-07-26